Previous Dutch auctions have been under a high degree of scrutiny in a market that was aggressive. Now the pricing favors the consumer. |
Prudential will be the third jewel of the insurance crown. |
Quality seems to ooze from every pore. |
Supply is going to be an issue that will be an overhang for the stock. |
The acute hospital sector does not have the sex appeal that people have been waiting for. Yet, it's a reliable sector that does not have across-the-board saturation. |
The company appears to be growing at some rather staggering rates as far as their top line. The big question now is if the 39 percent increase in the value of company is warranted. |
The consensus on the Street is that the current valuation won't be what they could have gotten last year. |
The deals are priced too high. For deals to crack like this, if there was perceived value these stocks they would not be falling apart the way they have. |
The deals have to be stronger now. It's less about perception and more about reality. This is different from what the market had been looking at. |
The dearth of deals in the fall means there's still a lot of pent-up demand showing up at the end of the year. |
The door has been pried open for tech stocks, but it's not a welcome. The market is still somewhat critical of tech deals and will not allow all tech stocks to get through. |
The Emerge offering is very regionally specific for people in the Midwest who understand the cattle industry. The company will bring in other investors if it can prove to be a viable platform. Right now, it's more of a flash in the pan and derivative of the business-to-business concept. |
The initial talk was for $3.6 billion. Now we're talking a valuation of $2.8 billion. |
The IPO market gives the outward appearance of a rebound but that is a false sense of confidence. The market is firming up and there are definitely upgrades but not all the signs are clear. |
The IPO market is being considered a luxury now. |